Back
ESC Premium Access

Dabigatran as first-line treatment for heparin-induced thrombocytopenia in the intensive cardiac care setting.

Session: Pharmacology and pharmacotherapy e-posters
Topic: Anticoagulants
Speaker: Doctor L. Szyda (Lodz, PL)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Lukasz Szyda

Bieganski Hospital, Lodz (Poland)
0 follower

57 more presentations in this session

Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials

Speaker: Doctor J. Borovac (Split, HR)

Access
Abstract
Slides
1
Thumbnail

The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus

Speaker: Doctor A. KANWAL (Valhalla, US)

Access
Abstract
Slides
0
Thumbnail

Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.

Speaker: Doctor K. Dzaurova (Moscow, RU)

Access
Abstract
Slides
0
Thumbnail

The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis

Speaker: Mrs A. Boulmpou (Thessaloniki, GR)

Access
Abstract
Slides
0
Thumbnail

Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis

Speaker: Mrs A. Boulmpou (Thessaloniki, GR)

Access
Abstract
Slides
1
Thumbnail

Access the full session

Pharmacology and pharmacotherapy e-posters

Speakers: Doctor L. Szyda, Doctor J. Borovac, Doctor A. KANWAL, Doctor K. Dzaurova, Mrs A. Boulmpou...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

Welcome and introduction.

27 August 2021

ESC Premium Access

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants among nonvalvular atrial fibrillation patients with prior bleeding events

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC 365 is supported by

logo Novo Nordisk